Recent Quarter Total Invested
$1.08 B
Recent Quarter Institutional Ownership Percentage
84.55%
Total Invested of Last Quarter
$909.65 M
Ownership Percentage of Last Quarter
86.85%
BioCryst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 19.96 M | $123.33 M | 8.22% | 9.68% |
| VANGUARD GROUP INC | 08/13/2024 | 18.77 M | $116.00 M | 6.18% | 9.11% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 12.57 M | $77.68 M | -3.68% | 6.10% |
| STATE STREET CORP | 08/14/2024 | 9.35 M | $57.76 M | -46.52% | 4.54% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2024 | 8.83 M | $54.55 M | 35.22% | 4.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 8.14 M | $50.28 M | 62.88% | 3.95% |
| ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 7.10 M | $43.87 M | 73.18% | 3.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 4.71 M | $29.12 M | 7.05% | 2.29% |
| CALIGAN PARTNERS LP | 08/14/2024 | 4.60 M | $28.42 M | 506.29% | 2.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 4.50 M | $27.78 M | 71.59% | 2.18% |
| RP MANAGEMENT, LLC | 08/13/2024 | 3.85 M | $23.77 M | 0.00% | 1.87% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 3.62 M | $22.37 M | 3.52% | 1.76% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 3.40 M | $21.04 M | -1.42% | 1.65% |
| FISHER ASSET MANAGEMENT, LLC | 08/14/2024 | 2.86 M | $17.65 M | -0.97% | 1.39% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 2.59 M | $16.01 M | 167.73% | 1.26% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 2.53 M | $15.64 M | 31.42% | 1.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 2.14 M | $13.20 M | 361.84% | 1.04% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2024 | 2.08 M | $12.85 M | -3.34% | 1.01% |
| CUTTER CAPITAL MANAGEMENT, LP | 08/14/2024 | 1.98 M | $12.21 M | -6.18% | 0.96% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 1.95 M | $12.05 M | 1,390.33% | 0.95% |
| FMR LLC | 08/13/2024 | 1.94 M | $12.00 M | 5.84% | 0.94% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 1.92 M | $11.86 M | -22.39% | 0.93% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 1.87 M | $11.53 M | -20.11% | 0.91% |
| STIFEL FINANCIAL CORP | 08/13/2024 | 1.84 M | $11.39 M | -0.02% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 1.79 M | $11.03 M | 3.08% | 0.87% |
| NORTHERN TRUST CORP | 08/14/2024 | 1.75 M | $10.84 M | -2.79% | 0.85% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.75 M | $10.82 M | -4.30% | 0.85% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 1.67 M | $10.35 M | 6.33% | 0.81% |
| MORGAN STANLEY | 10/17/2024 | 1.58 M | $9.75 M | -21.42% | 0.77% |
| SEGALL BRYANT & HAMILL, LLC | 08/14/2024 | 1.53 M | $9.43 M | -12.75% | 0.74% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.30 M | $8.04 M | -4.82% | 0.63% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 1.15 M | $7.12 M | -19.54% | 0.56% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 1.11 M | $6.87 M | 528.02% | 0.54% |
| SARISSA CAPITAL MANAGEMENT LP | 08/14/2024 | 1.09 M | $6.76 M | 0.00% | 0.53% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 1.04 M | $6.41 M | 786.98% | 0.50% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 960,180 | $5.93 M | -39.63% | 0.47% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/14/2024 | 846,844 | $5.23 M | -15.26% | 0.41% |
| JANE STREET GROUP, LLC | 08/15/2024 | 839,508 | $5.19 M | -24.82% | 0.41% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 800,000 | $4.94 M | 0.00% | 0.39% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 782,664 | $4.84 M | 8.79% | 0.38% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 775,957 | $4.80 M | 12.51% | 0.38% |
| JPMORGAN CHASE & CO | 08/12/2024 | 747,531 | $4.62 M | 177.81% | 0.36% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 739,599 | $4.57 M | 373.74% | 0.36% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 704,500 | $4.35 M | -0.70% | 0.34% |
| ALPHACENTRIC ADVISORS LLC | 07/25/2024 | 675,000 | $4.17 M | 0.00% | 0.33% |
| NORGES BANK | 08/14/2024 | 651,635 | $4.03 M | 100.00% | 0.32% |
| PANAGORA ASSET MANAGEMENT INC | 07/29/2024 | 650,318 | $4.02 M | 2.81% | 0.32% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 543,241 | $3.36 M | 18.78% | 0.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 08/14/2024 | 535,558 | $3.31 M | 0.00% | 0.26% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 465,731 | $2.88 M | -70.33% | 0.23% |
BioCryst Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of BCRX shares?
During the previous two years, 234 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Aspire Private Capital, LLC: 0
Pacer Advisors, Inc.: 0
OLIVER LAGORE VANVALIN INVESTMENT GROUP: 0
NATIONAL BANK OF CANADA /FI/: 0
MATHER GROUP, LLC.: 0
North Star Investment Management Corp.: 0
-
What percentage of BioCryst Pharmaceuticals, Inc. stock is owned by institutional investors?
84.55% of BioCryst Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at BCRX ?
Institutional investors have bought a total of 174.61 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.